Public-private partnerships in drug development for underdeveloped countries: an interview with Craig Wheeler, President of Chiron's Biopharmaceutical Division. Interview by Thomasine Kushner.
Wheeler
Craig
C
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003299:Cooperative Behavior; D003906:Developing Countries; D004345:Drug Industry / Q000191:economics* / Q000941:ethics; D006801:Humans; D007373:Interinstitutional Relations; D007769:Lactams / Q000627:therapeutic use; D017149:Private Sector / Q000191:economics*; D017150:Public Sector / Q000191:economics*; D012109:Research Support as Topic / Q000458:organization & administration*; D014376:Tuberculosis / Q000188:drug therapy / Q000191:economics
D000900:Anti-Bacterial Agents; D007769:Lactams; C035635:antibiotic PS 8